163 related articles for article (PubMed ID: 30261624)
1. Anticancer and Differentiation Properties of the Nitric Oxide Derivative of Lopinavir in Human Glioblastoma Cells.
Basile MS; Mazzon E; Krajnovic T; Draca D; Cavalli E; Al-Abed Y; Bramanti P; Nicoletti F; Mijatovic S; Maksimovic-Ivanic D
Molecules; 2018 Sep; 23(10):. PubMed ID: 30261624
[TBL] [Abstract][Full Text] [Related]
2. Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo.
Paskas S; Mazzon E; Basile MS; Cavalli E; Al-Abed Y; He M; Rakocevic S; Nicoletti F; Mijatovic S; Maksimovic-Ivanic D
Invest New Drugs; 2019 Oct; 37(5):1014-1028. PubMed ID: 30706336
[TBL] [Abstract][Full Text] [Related]
3. Effects of NO-Hybridization on the Immunomodulatory Properties of the HIV Protease Inhibitors Lopinavir and Ritonavir.
Fagone P; Mangano K; Quattrocchi C; Cavalli E; Mammana S; Lombardo GA; Pennisi V; Zocca MB; He M; Al-Abed Y; Nicoletti F
Basic Clin Pharmacol Toxicol; 2015 Nov; 117(5):306-15. PubMed ID: 25903922
[TBL] [Abstract][Full Text] [Related]
4. The Glucose Transporter PfHT1 Is an Antimalarial Target of the HIV Protease Inhibitor Lopinavir.
Kraft TE; Armstrong C; Heitmeier MR; Odom AR; Hruz PW
Antimicrob Agents Chemother; 2015 Oct; 59(10):6203-9. PubMed ID: 26248369
[TBL] [Abstract][Full Text] [Related]
5. Lopinavir/Ritonavir Treatment Induces Oxidative Stress and Caspaseindependent Apoptosis in Human Glioblastoma U-87 MG Cell Line.
Gratton R; Tricarico PM; Guimaraes RL; Celsi F; Crovella S
Curr HIV Res; 2018; 16(2):106-112. PubMed ID: 29804534
[TBL] [Abstract][Full Text] [Related]
6. Ritonavir, nelfinavir, saquinavir and lopinavir induce proteotoxic stress in acute myeloid leukemia cells and sensitize them for proteasome inhibitor treatment at low micromolar drug concentrations.
Kraus M; Müller-Ide H; Rückrich T; Bader J; Overkleeft H; Driessen C
Leuk Res; 2014 Mar; 38(3):383-92. PubMed ID: 24418752
[TBL] [Abstract][Full Text] [Related]
7. HIV protease inhibitors induce senescence and alter osteoblastic potential of human bone marrow mesenchymal stem cells: beneficial effect of pravastatin.
Hernandez-Vallejo SJ; Beaupere C; Larghero J; Capeau J; Lagathu C
Aging Cell; 2013 Dec; 12(6):955-65. PubMed ID: 23795945
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of ER stress response into HIV protease inhibitors: lopinavir but not darunavir induces potent ER stress response via ROS/JNK pathway.
Taura M; Kariya R; Kudo E; Goto H; Iwawaki T; Amano M; Suico MA; Kai H; Mitsuya H; Okada S
Free Radic Biol Med; 2013 Dec; 65():778-788. PubMed ID: 23973637
[TBL] [Abstract][Full Text] [Related]
9. The effect of lopinavir/ritonavir and lopinavir/ritonavir loaded PLGA nanoparticles on experimental toxoplasmosis.
Abou-El-Naga IF; El Kerdany ED; Mady RF; Shalaby TI; Zaytoun EM
Parasitol Int; 2017 Dec; 66(6):735-747. PubMed ID: 28838776
[TBL] [Abstract][Full Text] [Related]
10. Improving the efficacy of proteasome inhibitors in the treatment of renal cell carcinoma by combination with the human immunodeficiency virus (HIV)-protease inhibitors lopinavir or nelfinavir.
Abt D; Besse A; Sedlarikova L; Kraus M; Bader J; Silzle T; Vodinska M; Slaby O; Schmid HP; Engeler DS; Driessen C; Besse L
BJU Int; 2018 Apr; 121(4):600-609. PubMed ID: 29161753
[TBL] [Abstract][Full Text] [Related]
11. HIV protease inhibitor Lopinavir induces apoptosis of primary effusion lymphoma cells via suppression of NF-κB pathway.
Kariya R; Taura M; Suzu S; Kai H; Katano H; Okada S
Cancer Lett; 2014 Jan; 342(1):52-9. PubMed ID: 24012878
[TBL] [Abstract][Full Text] [Related]
12. Effects of ritonavir-boosted darunavir, atazanavir and lopinavir on adipose functions and insulin sensitivity in murine and human adipocytes.
Capel E; Auclair M; Caron-Debarle M; Capeau J
Antivir Ther; 2012; 17(3):549-56. PubMed ID: 22293506
[TBL] [Abstract][Full Text] [Related]
13. Lopinavir-Ritonavir Combination Induces Endoplasmic Reticulum Stress and Kills Urological Cancer Cells.
Okubo K; Isono M; Asano T; Sato A
Anticancer Res; 2019 Nov; 39(11):5891-5901. PubMed ID: 31704813
[TBL] [Abstract][Full Text] [Related]
14. Anticancer drug candidate CBL0137, which inhibits histone chaperone FACT, is efficacious in preclinical orthotopic models of temozolomide-responsive and -resistant glioblastoma.
Barone TA; Burkhart CA; Safina A; Haderski G; Gurova KV; Purmal AA; Gudkov AV; Plunkett RJ
Neuro Oncol; 2017 Feb; 19(2):186-196. PubMed ID: 27370399
[TBL] [Abstract][Full Text] [Related]
15. Nelfinavir and lopinavir impair Trypanosoma cruzi trypomastigote infection in mammalian host cells and show anti-amastigote activity.
Sangenito LS; d'Avila-Levy CM; Branquinha MH; Santos ALS
Int J Antimicrob Agents; 2016 Dec; 48(6):703-711. PubMed ID: 27838277
[TBL] [Abstract][Full Text] [Related]
16. Lack of interaction of lopinavir solid drug nanoparticles with cells of the immune system.
Liptrott NJ; Giardiello M; McDonald TO; Rannard SP; Owen A
Nanomedicine (Lond); 2017 Sep; 12(17):2043-2054. PubMed ID: 28805110
[TBL] [Abstract][Full Text] [Related]
17. Impact of darunavir, atazanavir and lopinavir boosted with ritonavir on cultured human endothelial cells: beneficial effect of pravastatin.
Auclair M; Afonso P; Capel E; Caron-Debarle M; Capeau J
Antivir Ther; 2014; 19(8):773-82. PubMed ID: 24535489
[TBL] [Abstract][Full Text] [Related]
18. Primary evidence of the mechanisms of action of HIV aspartyl peptidase inhibitors on Trypanosoma cruzi trypomastigote forms.
Sangenito LS; Menna-Barreto RFS; Oliveira AC; d'Avila-Levy CM; Branquinha MH; Santos ALS
Int J Antimicrob Agents; 2018 Aug; 52(2):185-194. PubMed ID: 29635008
[TBL] [Abstract][Full Text] [Related]
19. Proscillaridin A is cytotoxic for glioblastoma cell lines and controls tumor xenograft growth in vivo.
Denicolaï E; Baeza-Kallee N; Tchoghandjian A; Carré M; Colin C; Jiglaire CJ; Mercurio S; Beclin C; Figarella-Branger D
Oncotarget; 2014 Nov; 5(21):10934-48. PubMed ID: 25400117
[TBL] [Abstract][Full Text] [Related]
20. A Modified P1 Moiety Enhances In Vitro Antiviral Activity against Various Multidrug-Resistant HIV-1 Variants and In Vitro Central Nervous System Penetration Properties of a Novel Nonpeptidic Protease Inhibitor, GRL-10413.
Amano M; Salcedo-Gómez PM; Zhao R; Yedidi RS; Das D; Bulut H; Delino NS; Sheri VR; Ghosh AK; Mitsuya H
Antimicrob Agents Chemother; 2016 Dec; 60(12):7046-7059. PubMed ID: 27620483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
